STAT: First Opinion | 2 September 2018
Headlining >>>
FDA’s continuing use of ‘black box’ for antidepressants ignores the harms of this warning | By STEPHEN SOUMERAI AND ROSS KOPPEL
SPONSOR CONTENT BY STAT PLUS
In-depth biopharma, business, and policy analysis at your fingertips… Read More STAT: First Opinion | 2 September 2018